Abstract
From 1990 to 2021, the global incidence of uterine fibroids (UF) has steadily risen, with South Asia experiencing the greatest impact. Despite the stabilization of the age-standardized disability rate (ASDR), the rise in age-standardized incidence (ASIR) and prevalence (ASPR) remains a significant public health challenge worldwide. Health inequality analysis indicates that the burden of UF is shifting toward low Socio-Demographic Index (SDI) countries. Future prevention and treatment strategies for UF should focus on middle- and low-income countries, specifically by implementing targeted screening programs, investing in low-cost diagnostic tools, and launching public health awareness campaigns. Global public health cooperation, along with early diagnosis and treatment strategies for UF, will be crucial in reducing the disease burden.
Introduction
Uterine fibroids (UF) are the most common benign tumors of the female reproductive system. Despite their prevalence, their global epidemiological landscape has remained under-researched, with previous studies often limited by regional focus or outdated datasets. This study addresses critical gaps by analyzing spatiotemporal trends, health inequalities, and future projections of the UF burden globally over the last three decades. Understanding these factors is essential for effective resource allocation, as UF significantly impacts quality of life, fertility, and economic productivity.
Methods
The study utilized data from the Global Burden of Disease (GBD) 2021 study, covering 204 countries and territories. Researchers employed several statistical tools:
- Estimated Annual Percentage Change (EAPC): To quantify the average annual rate of change in age-standardized rates (ASR).
- Socio-Demographic Index (SDI): To correlate development status with disease burden.
- Health Inequality Metrics: Using the Slope Index of Inequality (SII) and Concentration Index to measure disparities across SDI levels.
- Bayesian Age-Period-Cohort (BAPC) Model: To project trends up to 2036.
Key Insights: Demographic and Regional Trends
A significant finding is the "Low-SDI Shift." While UF burden was historically concentrated in high-SDI countries due to better diagnostics, it is now rapidly shifting toward low-SDI regions. Furthermore, while inequality in incidence is decreasing, inequality in Disability-Adjusted Life Years (DALYs) is worsening, suggesting that women in low-income areas lack access to effective treatment despite increasing diagnosis rates.
The global burden also shows distinct age-related patterns. Incidence peaks in the 35–39 age group, while prevalence and DALYs peak slightly later, in the 40–44 age group.
Key Results
- Rising Incidence and Prevalence: The global Age-Standardized Incidence Rate (ASIR) rose from 234.36 to 250.93 per 100,000 between 1990 and 2021. The total number of prevalent cases nearly doubled, reaching approximately 119.5 million by 2021.
- DALY Stabilization: Although total DALYs increased, the age-standardized disability rate (ASDR) remained stable (3.48 vs 3.39), indicating that the per-capita disability impact has not significantly worsened despite the rise in cases.
Future Projections and Limitations
The BAPC model predicts continued rises in ASIR and ASPR through 2036, though ASDR may decline slightly due to advancements in minimally invasive treatments.
However, the study notes limitations, including potential underestimation in low- and middle-income countries (LMICs) due to data scarcity and the asymptomatic nature of many UF cases. Future research should focus on region-specific risk factors and the cost-effectiveness of interventions in resource-limited settings to guide global health strategies.
Summary updated